{{Rsnum
|rsid=1799722
|Gene=BDKRB2
|Chromosome=14
|position=96204802
|Orientation=plus
|GMAF=0.3783
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=BDKRB2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 29.2 | 50.4 | 20.4
| HCB | 21.9 | 45.3 | 32.8
| JPT | 23.0 | 50.4 | 26.5
| YRI | 58.5 | 38.1 | 3.4
| ASW | 45.6 | 40.4 | 14.0
| CHB | 21.9 | 45.3 | 32.8
| CHD | 31.2 | 41.3 | 27.5
| GIH | 37.6 | 47.5 | 14.9
| LWK | 59.1 | 37.3 | 3.6
| MEX | 32.8 | 53.4 | 13.8
| MKK | 48.4 | 45.1 | 6.5
| TSI | 33.3 | 40.2 | 26.5
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1799722
|Name_s=BDKRB2 C-58T; BDRKRB2:(-58)C>T
|Gene_s=BDKRB2
|Feature=
|Evidence=PubMed ID:11130770; PubMed ID:11409654
|Annotation=The -58C allele of the human beta2 bradykinin receptor gene has been associated with hypertension in a Chinese Han population and an African American population.
|Drugs=
|Drug Classes=
|Diseases=Hypertension
|Curation Level=Curated
|PharmGKB Accession ID=PA164925764
}}

{{PMID Auto
|PMID=20511677
|Title=No association between alleles of the bradykinin receptor-B2 gene and acute mountain sickness
}}
{{PMID Auto
|PMID=20044476
|Title=Associations of polymorphisms of eight muscle- or metabolism-related genes with performance in Mount Olympus marathon runners
}}

{{PharmGKB
|RSID=rs1799722
|Name_s=BDKRB2 C-58T; BDRKRB2:(-58)C>T
|Gene_s=BDKRB2
|Feature=
|Evidence=PubMed ID:10904024; PubMed ID:11699055; PubMed ID:12522467
|Annotation=The T allele at this position has been associated with ACE inhibitor-related cough in two Japanese studies but not in a study of Chinese women.
|Drugs=
|Drug Classes=ACE INHIBITORS, PLAIN
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA164925765
}}

{{PMID Auto
|PMID=15643125
|Title=Sequence variation of bradykinin receptors B1 and B2 and association with hypertension.
}}

{{PMID Auto
|PMID=15717931
|Title=Identification of functional SNPs in the 5-prime flanking sequences of human genes.
|OA=1
}}

{{PMID Auto
|PMID=17207964
|Title=Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1799722
|overall_frequency_n=52
|overall_frequency_d=128
|overall_frequency=0.40625
|n_genomes=36
|n_genomes_annotated=0
|n_haplomes=46
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}